STOCK TITAN

BioCryst to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
BioCryst Pharmaceuticals, Inc. (BCRX) will present at two upcoming healthcare conferences in March 2024, providing investors with valuable insights. The presentations will be held at the TD Cowen 44th Annual Health Care Conference and the Barclays 26th Annual Global Healthcare Conference, offering live audio webcasts and replays for interested parties.
Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the TD Cowen 44th Annual Health Care Conference in Boston on Wednesday, March 6, 2024, at 10:30 a.m. ET and the Barclays 26th Annual Global Healthcare Conference in Miami on Tuesday, March 12, 2024, at 7:30 a.m. ET.

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com


FAQ

When will BioCryst Pharmaceuticals present at the TD Cowen 44th Annual Health Care Conference?

BioCryst Pharmaceuticals will present at the TD Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024, at 10:30 a.m. ET.

Which conference will BioCryst Pharmaceuticals attend on Tuesday, March 12, 2024?

BioCryst Pharmaceuticals will attend the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 7:30 a.m. ET.

Where can investors access the live audio webcasts and replays of the presentations?

Investors can access the live audio webcasts and replays of the presentations in the Investors & Media section of BioCryst's website at http://www.biocryst.com.

BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

BCRX Rankings

BCRX Latest News

BCRX Stock Data

1.60B
206.38M
1.16%
89.95%
14.38%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
DURHAM